NIKI NIKI
Company Profile ↓Company Overview
NIKI (NIKI) is a publicly traded company listed on with a market capitalization of $76.47M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.15.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -33.87% |
| 6 Months: | +6.70% |
| 3 Months: | +8.06% |
| 1 Month: | +21.95% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)56.26 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 77.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Sep 2025 | Dec 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | - | - | - |
| Gross Profit | - | - | - |
| Operating Expenses | -558.60K | 589.63K | 825.13K |
| Operating Income | 558.60K | -589.63K | -825.13K |
| EBITDA | 275.92K | -589.63K | -825.13K |
| Interest Expense | - | 26.96K | - |
| Pretax Income | -770.35K | -616.60K | -310.54K |
| Tax Provision | - | - | - |
| Net Income | -919.90K | -614.00K | -307.50K |
| Diluted EPS | - | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 1.30M | 431.38K | 0 | 0 |
| Cost of Revenue | - | 1.22M | 420.81K | 0 | 0 |
| Gross Profit | - | 80.06K | 10.57K | 0 | 0 |
| Operating Expenses | - | 17.25M | 10.61M | 3.00M | 1.82M |
| Operating Income | - | -17.17M | -10.60M | -3.00M | -1.82M |
| EBITDA | - | -15.62M | -9.22M | -2.70M | -1.82M |
| Interest Expense | 93.60K | - | - | - | - |
| Pretax Income | - | -11.53M | -4.34M | -4.16M | -1.38M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -9.80M | -2.82M | -4.27M | -1.36M |
| Diluted EPS | -7.15 | -2.75 | -0.62 | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 20.87M | 20.64M | 16.13M | 18.69M |
| Current Assets | - | 7.07M | 2.48M | 959.55K | 3.59M |
| Cash & Equivalents | - | 1.88M | 2.01M | 874.24K | 3.45M |
| Inventory | 35.77K | 27.72K | 0 | - | - |
| Receivables | 78.72K | 174.43K | 47.71K | 0 | - |
| Total Liabilities | - | 13.03M | 5.26M | 4.35M | 4.90M |
| Current Liabilities | - | 12.50M | 2.10M | 4.34M | 4.59M |
| Long Term Debt | - | 500.00K | 3.06M | - | - |
| Total Debt | - | 6.85M | 3.28M | 3.35M | 3.44M |
| Total Equity | - | 15.71M | 24.85M | 21.13M | 23.16M |
| Shares Outstanding | - | 3.57M | 5.18M | 5.61M | 8.14M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -12.32M | -7.72M | -1.19M | -1.84M |
| Investing Cash Flow | - | 2.44M | 624.77K | 58.62K | 0 |
| Financing Cash Flow | - | 6.63M | 4.09M | 0 | 4.42M |
| Capital Expenditure | -137.78K | -186.92K | -3.02K | - | - |
| Free Cash Flow | - | -12.51M | -7.73M | -1.19M | -1.84M |
| Net Change in Cash | - | -3.25M | -3.01M | -1.13M | 2.58M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 6.2% | 2.4% | - | - |
| Operating Margin % | - | -1,325.2% | -2,457.5% | - | - |
| Net Margin % | - | -756.2% | -654.8% | - | - |
| ROE % | - | -62.4% | -11.4% | -20.2% | -5.9% |
| ROCE % | - | -205.3% | -57.2% | -25.5% | -12.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NIKI
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE02ZENiR28tVTQ2RFN6cF9LcmZmckF0TGdMRzJHS1VKMzFHWUg3dEhxeFRBWkdUYkJ3NEhWMW1XXzQxR3BFUTNLLVpoOFN5SFV0?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
NIKI BIOSOLUTIONS INC, (NIKI) Stock News - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiTkFVX3lxTE5oOU1ZRkU1bk1ORW9BUVg5Z0p3N3NTMm9aY1NvemJxWEZiM0w3dzZxd2dmVktCb1FMQmRITHQxZmhTWUg1SGw4UG9ic0hQdw?oc=5" target="_blank">NIKI BIOSOLUTIONS INC, (NIKI) Stock News</a> <font…
Operating margin % of Niki BioSolutions, Inc. – NASDAQ:NIKI - TradingView
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNeXl1cF85ZXdyd0pLaWJmdG51VWZJTGUwZE5GeXU5b3BqR3BfQUktX3V2bzhUbHItT3c0T1pLRGEySnlreHpWSG1BVnprYkp3cURXLWpjbkdDZ3dFVjlPbk4zOEtyNjI1aERVOXV2NS1tc19YNmZ6el8xZ0I0b3dhRnI0Y09yZUx6RGJCSU…
NIKI | Niki BioSolutions, Inc. Common Institutional Ownership - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTE9jc3RnZ0o2ZHJYNV9CdThBY0VrRHNMNzVSZ0o0bTZKMG1sZEc0VW5EdlRMNXhET183OEJQdGdxWGNEeWpUeDRTZDVJVTVIMDBVcXA3eDBIdG9Pc0JSeFV5SmpB?oc=5" target="_blank">NIKI | Niki BioSolutions, Inc. Comm…
NIKI BIOSOLUTIONS INC, (NIKI) Stock Price, News & Analysis - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE1haXVMLU1OZHRUNnpLTFNDbTJaazZheEUzMGtsTlVMdnRZVFlZRDMwcUd6UXNMOTZCa0lEUWdGLTcwMWdhemZzSXpubUJJelViUzVv?oc=5" target="_blank">NIKI BIOSOLUTIONS INC, (NIKI) Stock Price, News & Analy…
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQaDRLRWxVZEJsazJWOC1IdUVsb3dkMF9hazhGYWRja0s1a1lmSzRjb01iMzAyRWtNZjRuTWtWZG56aGg1eUlDbnpob3JzQnVlNHpuT3NmZWstQ2NMREFYOTNVR2F5ak1MYWtoWDB0TVg3R1hsVEtIY2xRODZBQV83Qkt5c3ZETURnX3lCaV…
NIKI — Frequently Asked Questions
What is the current share price of NIKI?
As of 2026-08-05 17:25 PDT, NIKI trades at $9.39 on NASDAQ/NYSE. Its 52-week range is $6.92 to $42.50.
What is the market capitalisation of NIKI?
NIKI has a market capitalisation of $76.47M on NASDAQ/NYSE.
What is the P/E ratio of NIKI?
NIKI trades at a trailing price-to-earnings (P/E) ratio of -15.15. Its price-to-book (P/B) ratio is 3.30.
What is the return on equity (ROE) of NIKI?
NIKI has a return on equity (ROE) of -5.89%. Its return on capital employed (ROCE) is -12.89%.
Is NIKI a good stock to buy?
This page provides a data-driven analysis of NIKI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.